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Abstract

Previous kinetic characterization of the glutamate 151 (E151)-substituted forms of the leucine aminopeptidase
from Aeromonas proteolytica (Vibrio proteolyticus; AAP) has provided critical evidence that this residue
functions as the general acid/base. The close proximity of similar glutamate residues to the bridging
water/hydroxide of the dinuclear active sites of metalloenzymes (2.80 and 3.94 Å in carboxypeptidase G2 and
3.30 and 3.63 Å in AAP), suggests it may also be involved in stabilizing the active-site metal ions. Therefore, the
structural perturbations of the dinuclear active site of AAP were examined for two E151-substituted forms,
namely E151D-AAP and E151A-AAP, by UV−vis and electron paramagnetic resonance (EPR) spectroscopy. UV−vis
spectroscopy of Co(II)-substituted E151A-AAP did not reveal any significant changes in the electronic absorption
spectra. However UV−vis spectra of mono- and dicobalt(II) E151D-AAP exhibited a lower molecular absorptivity
compared to AAP (23 and 43 M-1 cm-1 vs. 56 and 109 M-1 cm-1 for E151D-AAP and AAP, respectively) suggesting
both Co(II) ions reside in distorted octahedral coordination geometry in E151D-AAP. EPR spectra of [Co_(E151DAAP)], [ZnCo(E151D-AAP)], and [(CoCo(E151D-AAP)] were identical, with g⊥ = 2.35, g∥ = 2.19, and E/D = 0.19,
similar to [CoCo(AAP)]. On the other hand, the EPR spectrum of [Co_(E151A-AAP)] was best simulated assuming
the presence of two species with (i) gx,y = 2.509, gz = 2.19, E/D = 0.19, A = 0.0069 cm-1 and (ii) gx,y = 2.565, gz =
2.19, E/D = 0.20, A = 0.0082 cm-1 indicative of a five- or six-coordinate species. Isothermal titration calorimetry
experiments revealed a large decrease in Zn(II) affinities, with Kd values elevated by factors of ∼850 and
∼24 000 for the first metal binding events of E151D- and E151A-AAP, respectively. The combination of these
data indicates that E151 serves to stabilize the dinuclear active site of AAP.

Abbreviations: rAAP, recombinant leucine aminopeptidase from Aeromonas proteolytica (Vibrio proteolyticus);
BuBA, 1-butaneboronic acid; CPG2, carboxypeptidase G2; GCP II, glutamate carboxypeptidase II; HEPES, 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid; IPTG, isopropyl-β-D-thiogalactopyranoside; ICP-AES, inductively
coupled plasma-atomic emission spectrometry; ITC, Isothermal Titration Calorimetry; L-pNA, l-leucine-pnitroanilide; Tricine, N-tris[hydroxymethyl]methylglycine; WT, wild type.

Synopsis
Combination of the kinetic, ITC, and spectroscopic data presented herein has allowed the structural role of
glutamate-151 (E151) to be examined. E151 acts on several levels: (i) stabilizing the active site, (ii) preserving
the coordination geometry of the first, “tightly bound” metal ion, (iii) affecting the Lewis acidity of the metal
ions through the interaction with the bridging water molecule as well as other metal ligands, (iv) positioning the
nucleophile relative to the substrate, and (v) acting as a general acid in the proposed mechanism of peptide
hydrolysis by assisting in the collapse of the tetrahedral intermediate.
Dinuclear metallohydrolases are a large class of enzymes that are capable of degrading peptide, β-lactam, and
ester bonds, making them important components in cellular protein turnover, antibiotic resistance, and

homeostasis.1-3 These enzymes have been implicated in angiogenesis, protein degradation and processing,
neurological disorders, HIV infection, and resistance of bacteria to certain antibiotics.2-7 Of particular interest to
our research are co-catalytic metallopeptidases from clans M20 and M28-leucine
aminopeptidase from Vibrio proteolyticus (AAP; previously miscast as Aeromonas proteolytica),
carboxypeptidase G2 from Pseudomonas sp. Strain RS-16 (CPG2), N-succinyl-l,l-2,6-diaminopimelate
desuccinylase (DapE), N-acetyl ornithine deacetylase (ArgE), and glutamate carboxypeptidase II (GCP II) found in
humans.1,8,9 CPG2 has been successfully used in antibody directed enzyme-prodrug therapy (ADEPT), as well as in
rescue therapy following a large dose of administered methotrexate.10,11 GCP II, which is localized in the brain,
liver, kidney, and prostate, is involved in processing of N-acetyl-aspartyl-glutamate (NAAG), a neurotransmitter,
and thus is believed to be involved in neurological disorders.1,7,12 DapE and ArgE are present only in bacteria and
are involved in lysine (DapE) and arginine (ArgE) biosynthesis, making them promising antibacterial targets.8,9,1315
While the role of AAP in nature is unknown, it shares high sequence homology to the C-terminal
hemagglutinin/protease from V. cholerae, a pathogenic microorganism.16
Amino acid sequence alignment of the active site regions of metallopeptidases from clans M20 and M28 show a
significant degree of similarity (Table 1). Superposition of the active sites of X-ray crystallographically
characterized enzymes (aminopeptidase from S. griceus (SAP), AAP, and CPG2) reveals an identical and highly
conserved architecture of their active sites.17-19 The co-catalytic active site of AAP, structurally characterized to
1.2 Å resolution contains a (μ-aquo)(μ-carboxylato)dizinc(II) core with a terminal carboxylate and histidine
residue at each metal ion resulting in symmetric coordination spheres for the two active site Zn(II) ions.17,20 Both
Zn(II) ions reside in distorted tetrahedral coordination geometries with a Zn−Zn distance of 3.5 Å. A glutamate
residue, E151, forms a hydrogen bond with the bridging water molecule. Although Zn(II) is the native active-site
metal ion for all of these enzymes, studies on AAP and DapE revealed that these enzymes can be activated by
several first row transition metals.21,22 Bennett and Holz demonstrated that metal binding to AAP occurs in a
sequential fashion,23 highlighting the potential for the formation of heterodimetallic sites. Heterodimetallic
centers provide systems in which the function of each metal binding site can be probed through independent
labeling with spectroscopically active and silent metal ions.
Table 1. Comparison of Amino Acids in the Active Sites of Selected Dinuclear Metalloenzymesa
AAP CPG2 SAP
GCP II proposed function
H97 H112 H85 H377 Zn2+ binding
D99 D114 D87 D379 hydrogen bondingb
D117 D141 D97 D387 Zn2+ binding
E151 E175 E131 E424 general baseb
E152 E175 E131 E424 Zn2+ binding
D179 E200 D160 D453 Zn2+ binding
H256 H385 H247 H553 Zn2+ binding
a
Speno, et al. Mol. Pharmacol.1999, 55, 179−185.b Proposed role.
In the proposed catalytic mechanism of peptide hydrolysis, an important role has been assigned to an active-site
glutamate residue (E151) of AAP. This amino acid was recently shown to function as the active-site general
acid/base by deprotonating the bridging water molecule, generating a nucleophilic hydroxide, as well as
assisting in the collapse of the tetrahedral intermediate, thus facilitating formation of the product.24 This
glutamate residue is in close proximity to the bridging water species: its oxygen atoms are positioned 3.30 and
3.63 Å (AAP) and 2.75 and 3.85 Å (CPG2) from the bridging water/hydroxide, supporting its proposed
involvement in the deprotonation of this group.17 Additionally, the oxygen atoms of E151 of AAP are 3.2 Å from
one of the oxygen atoms of E152, one of the Zn1 ligands, and 3.4 Å from the Nε nitrogen of His97, one of the
Zn2 ligands. Therefore, E151 may be involved in the stabilization of the active site. To understand the structural

perturbations of the Zn(II) ions in the active site of AAP upon substitution of E151 with an aspartate or an
alanine residue, we have recorded the electronic absorption and EPR spectra of Co(II)-substituted forms of these
enzymes. In addition, isothermal titration calorimetry (ITC) was used to determine the metal binding constants
in rAAP, as well as the E151D and E151A variants of AAP. Combination of the data presented herein indicates
that E151 is crucial for the stability of the active site, most likely through hydrogen-bonding interactions with the
residues in the active site of AAP.

Materials and Methods
Protein Expression and Purification.

All materials used in this study were of the highest purity available and were purchased from Fisher or SigmaAldrich, unless stated otherwise. The E151D and E151A forms of AAP were prepared and purified as described
elsewhere.25

Enzymatic Assay.

During and after purification, the E151D and E151A forms of AAP were assayed for catalytic activity with lleucine-p-nitroanilide (L-pNA) as the substrate.26 In this assay, the hydrolysis of L-pNA was measured
spectrophotometrically by monitoring the formation of p-nitroaniline at 405 nm (ε = 10 800 M-1 cm-1) in a cell
with a 1-cm light path. All assays were performed on a Shimadzu UV-3101PC spectrophotometer equipped with
a constant-temperature cell holder and an Isotemp 2013D water bath (Fisher Scientific, Pittsburgh, PA). Enzyme
concentrations were determined from the absorbance at 280 nm with the value ε280 = 43 950 M-1 cm-1.27 All
assays were performed at 25 ± 0.1 °C unless stated otherwise. All experiments were carried out in 10 mM Tricine
buffer pH 8.0 with 0.1 mM ZnSO4, unless stated otherwise.

Apo-Enzyme Preparation.

Purified and concentrated E151A-AAP or E151D-AAP (10−20 mg/mL) was incubated with 10−15 mM disodium
EDTA at 4 °C until no activity was observed (usually 1−3 days). To remove EDTA, the protein was dialyzed
extensively against 100 times the volume of chelexed 50 mM HEPES buffer pH 7.5 (Chelex 100, BioRad). The
activity of the dialyzed apo-E151D-AAP was less than 1% of the activity of the enzyme reconstituted with 2 equiv
of Zn(II); metal content in the E151A form of AAP was determined by ICP-AES analysis (USU Agriculture
Department). All plastic-ware used for dialysis and the dialysis tubing were presoaked in a disodiumEDTA/bicarbonate solution to remove all traces of metals and then extensively washed with Nanopure water
(NANOpure Ultrapure Water System, Barnstead/Thermolyne, IA) and chelexed HEPES buffer.

Figure 1 Isothermal titration data for the titration of apo-rAAP with (left) Zn(II) and (right) Co(II) (50 mM HEPES
buffer pH 7.5 at 25 °C).

Isothermal Titration Calorimetry.

ITC measurements were carried out on a MicroCal OMEGA ultrasensitive titration calorimeter at 25 ± 0.2 °C.
Association constants (Ka) were obtained by fitting these data, after subtraction of the background heat of
dilution, via an interactive process using the Origin software package. This software package uses a nonlinear
least-squares algorithm, which allows the concentrations of the titrant and the sample to be fit to the heat-flowper-injection to an equilibrium binding equation for two noninteracting sites. The Ka value, enzyme−metal
stoichiometry (n), and the change in enthalpy (ΔH°) were allowed to vary during the fitting process. The divalent
metal ion titrants and apo-enzyme solutions were prepared in chelexed HEPES buffer at pH 7.5. Stock buffer
solutions were thoroughly degassed before each titration. The enzyme solution (60−90 μM) was placed in the
calorimeter cell and stirred at 200 rpm to ensure rapid mixing. Typically, 4−6 μL of titrant was delivered over 7.6
s with a 6 min interval between injections to allow for complete equilibration. Each titration was continued until
4.5−6 equiv of M(II) had been added to ensure that no additional complexes were formed in excess titrant. A
background titration, consisting of the identical titrant solution but only the buffer solution in the sample cell,
was subtracted from each experimental titration to account for heat of dilution. These data were analyzed with
a two- or three-site binding model by the Windows-based Origin software package supplied by MicroCal. The
heat of reaction, measured during the experiment, was converted into association constants (Ka) using the Gibbs
free energy relationship:

(1)

∆𝐺𝐺° = −𝑅𝑅𝑅𝑅 ln(𝐾𝐾a ) = ∆𝐻𝐻° − 𝑇𝑇∆𝑆𝑆°

where R = 1.9872 cal mol-1 K-1. The relationship between Ka and Kd is defined as

(2)

𝐾𝐾d = 1/𝐾𝐾a

Individual rAAP and altered rAAP enzyme solutions were prepared by diluting stock enzyme solutions with 50
mM chelexed HEPES buffer (pH 7.5).

Spectroscopic Measurements.

Electronic absorption spectra were recorded on a Shimadzu UV-3101PC spectrophotometer. All solutions used
for the experiment were degassed prior to use. The apo-protein (typically 0.3−1.2 mM) was incubated with Co(II)
(CoCl2: ≥ 99.999% Acros Organics, Geel, Belgium) for ∼10 min at 25 °C before a spectrum was recorded. The
apo-enzyme absorbance was subtracted from the spectra obtained with Co(II) using IgorPro (Wavemetrix, Inc.,
Lake Oswego, OR). EPR spectra were recorded using a Bruker ESP-300E spectrometer with an ER 4116 DM
TE102/TE012 dual-mode X-band cavity and an Oxford Instruments ESR-900 helium flow cryostat. All spectra were
recorded at a modulation frequency of 100 kHz and a modulation amplitude of 12.6 G (1.26 mT). Protein
concentrations used for EPR experiments were approximately 1 mM. Exact microwave frequencies and
temperatures for individual spectra are provided in the figure legends. Computer simulations of EPR spectra
were carried out using Xsophe v.1.1.2 (Bruker Biospin GmbH, Rheinstetten, Germany).28 Parameters were fit to
the spin Hamiltonian:

(3)

𝐻𝐻 = 𝛽𝛽gHS + SDS + SAI

Under this formalism, D > 0 corresponds to an MS = |±1/2〉ground state and D < 0 corresponds to an MS =
|±3/2〉 ground state.

Results
Enzymatic Activity of E151D- and E151A-AAP.

The observed kcat value for E151D-AAP is 2.24 min-1, which is 1900 times slower than that of rAAP (10 mM
Tricine buffer, pH 8.0, 0.2 M KCl, 0.1 mM ZnSO4); however, E151A-AAP is completely inactive.24,25 Interestingly,
the observed Km value for E151D-AAP is identical, within error, to WT AAP.

Metal Binding Properties of rAAP, E151D-, and E151A-AAP.

The best fits obtained for rAAP upon the addition of either Zn(II) or Co(II) provided n values of 2 for two
noninteracting sites (Figure 1; Table 2). The first binding site exhibited a Kd value of 0.003 μM for Zn(II) and 0.09
μM for Co(II) binding. These data are in good agreement with the Kd value determined for the binding of a single
Zn(II) ion by Baker and Prescott using equilibration dialysis (0.00015 μM).29 The observed Kd values for Zn(II) and
Co(II) binding to the second metal binding site for rAAP are 0.25 mM and 0.36 μM, respectively. The energy
change observed for both binding sites indicates an endothermic-type reaction providing a more positive
ΔH value for the second metal binding event; however, it is evident that the metal-ion binding process is
entropy-driven (Table 2). For E151D-AAP, Zn(II) and Co(II) binding provided one tight metal binding site
with Kd values of 2.7 and 14 μM, respectively, and one loose metal binding site which exhibited Kd values of 5.9
and 2.5 mM for Zn(II) and Co(II) binding, respectively. The first and second Zn(II) and Co(II) binding events were
endothermic (Table 2). For E151A-AAP, the best fit revealed two Zn(II) binding sites that exhibited Kd values of
75 and 429 μM for the first and second binding events, respectively. Similar to WT rAAP, the observed energy
change for both the first and second Zn(II) ion binding events is endothermic (Table 2). An interesting pattern
can be seen-binding of the first metal ion exhibits more negative Gibbs free energy, as compared to the second
binding event, while binding of the second metal ion is largely entropy driven.
Table 2. Metal Binding Constants and Thermodynamic Parameters for Co(II) and Zn(II) Binding to Apo E151D,
E151A, and Recombinant AAP
na
K1, K2 (M-1) ΔH1, ΔH2 (kcal mol-1)
[CoCo(E151D)] 0.89 7.11 × 104 1.25
1.28 3.99 × 102 7.27
[ZnZn(E151D)] 1.02 3.76 × 105 3.82
1.05 1.10 × 102 1.25
[ZnZn(E151A)] 1.30 1.34 × 102 1.89
1.12 2.33 × 104 20.7
[CoCo(rAAP)]
0.97 1.06 × 107 0.21
0.90 2.77 × 106 10.03
[ZnZn(rAAP)]
1.21 3.19 × 108 1.36
1.05 3.93 × 103 5.23
a
n, enzyme−metal stoichiometry; Ki, dissociation constant.

TΔS1, TΔS2 (kcal mol-1)
7.88
10.82
11.44
4.03
7.52
25.3
9.71
18.45
12.95
10.14

Electronic Absorption Spectra of rAAP, E151D-, and E151A-AAP.

ΔG1, ΔG2 (kcal mol-1)
−6.63
−3.55
−7.62
−3.05
−5.63
−4.59
−9.50
−8.42
−11.59
−4.91

Electronic absorption spectra of the mono- and dicobalt(II) forms of rAAP, E151D-AAP, and E151A-AAP were
recorded in 50 mM chelexed HEPES buffer, pH 7.5, and the component due to apo-AAP was subtracted (Table 3;
Figure 3). Similar to WT AAP, the addition of one Co(II) ion to rAAP provides a visible absorption spectrum with a
band at 525 nm (ε525 ≈ 56 M-1 cm-1). The addition of a second equivalent of Co(II) increases the absorption
intensity at 525 nm to ∼109 M-1 cm-1. The addition of more than 2 equiv of Co(II) does not significantly alter the
intensity or position of the observed absorption band. A portion of the added absorptivity (Δε525 of 53 M-1 cm-1)
appears to be due to a broad underlying protein absorption band that is not due to Co(II) absorption (ε425 = 15
M-1 cm-1). Therefore, the observed increase in absorption at 525 nm due to the second Co(II) ion is ∼38 M-1 cm-1.

The molar absorptivities and absorption maxima are consistent with the first Co(II) ion residing in a distorted
five-coordinate environment, while the second Co(II) ion resides in either a distorted five-coordinate or a very
distorted octahedral environment. These spectra are similar to those recorded by Prescott and co-workers.30 For
Co(II)-loaded E151D-AAP, the visible absorption spectrum revealed a band at 521 nm with an ε value of 23 M1
cm-1 for [Co_(E151D-AAP)]. Upon the addition of a second equivalent of Co(II), the λmax did not shift but the
molar absorptivity increased to 43 M-1 cm-1. On the other hand, the absorption maximum observed for
[Co_(E151A-AAP)] is 523 nm with a molar absorptivity of 48 M-1 cm-1 and a shoulder at 570 nm. The addition of
a second equivalent of Co(II) increased the molar absorptivity to 79 M-1 cm-1.

Figure 2 Isothermal titration data for the titration of (A) apo-E151D-AAP and (B) apo-E151A-AAP with Zn(II) (50
mM HEPES buffer pH 7.5 at 25 °C).

Figure 3 UV−vis spectra of rAAP, E151D-AAP, and E151A-AAP with Co(II) in 50 mM HEPES, pH 7.50.
Table 3. Comparison of Spectral Properties of rAAP and E151D, E151A AAPa
rAAP E151D E151A
maximum absorbance (nm)
525 521
523
-1
-1
molar absorptivity with 1 equiv of Co(II) (M cm ) 56
23
48
molar absorptivity with 2 equiv of Co(II) (M-1 cm-1) 109 43
79
a
Metal titration experiments were carried out in chelexed 50 mM HEPES, pH 7.5 with CoCl2 (99.999% Acros
Organics, Geel, Belgium). Protein concentration ranged from 0.6 to 1.2 mM

EPR Characterization of rAAP, E151D- and E151A-AAP.

EPR spectra of [CoZn(E151D-AAP)], [ZnCo(E151D-AAP)], and [CoCo(E151D-AAP)] recorded at 10 K are
indistinguishable (Figure 4). rAAP spectra are identical to those of WT AAP.23,31 Each of these spectra could be

simulated with g⊥(real) = 2.35 and g∥(real) ≈ 2.38 and E/D = 0.1 with D ≫ gβH (Figure 4). On the other hand, EPR
spectra of [Co_(E151A-AAP)] revealed the presence of resolved 59Co hyperfine lines, as is the case with
[Co_(WTAAP)], suggesting the presence of an additional rhombic species with g⊥(real) ≈ 2.5, E/D ≈ 0.2
and A(59Co) ≈ 0.0075 cm-1 (Figure 5). These data were best simulated with models including two distinct species
of equal intensities, with (i) gx,y = 2.509, gz = 2.19, E/D = 0.19, A = 0.0069 cm-1; (ii) gx,y = 2.565, gz = 2.19, E/D =
0.20, A = 0.0082 cm-1. The quality of the simulation can be judged by the reproduction of the hyperfine pattern
in the high-resolution EPR spectrum (Figure 5). For [CoCo(E151A-AAP)], a broad rhombic signal is observed
similar to [CoCo(WTAAP)] and was simulated with gx,y = 2.29, gz ≈ 2.55; E/D = 0.08 (Figure 6).

Figure 4 EPR spectra of metal-reconstituted E151D-AAP, pH 7.50. All spectra were recorded at 10 K, 0.2 mW
microwave power, 12.6 G field modulation amplitude, 100 kHz modulation frequency. (A) EPR spectrum of
[CoZn(E151D-AAP)]; (B) EPR spectrum of [ZnCo(E151D-AAP)]; (C) EPR spectrum of [CoCo(E151D-AAP)]; (D)
simulation of the spectra with gx,y = 2.35 and gz = 2.38, E/D = 0.1.

Figure 5 (A) Top: EPR spectrum of [Co_(E151A-AAP)] in HEPES buffer, pH 7.50 recorded at 10 K, 0.2 mW
microwave power, 12.6 G field modulation amplitude, 100 kHz modulation frequency. Bottom: simulation of
the EPR spectrum of [Co_(E151A-AAP)] with three species: (1) gx,y = 2.509, gz ≈ 2.19, E/D = 0.19, A = 0.0069 cm-1;
(2) gx,y = 2.565, gz ≈ 2.19, E/D = 0.20, A = 0.0082 cm-1; (3) gx,y = 2.29, gz ≈ 2.55, E/D = 0.08. (B) Low-field region of
the spectrum recorded at higher resolution and a correspondingly expanded view of the simulation.

Figure 6 Top: EPR spectrum of [(CoCo(E151A-AAP)] in HEPES buffer, pH 7.50 recorded at 10 K, 0.2 mW
microwave power, 12.6 G field modulation amplitude, 100 kHz modulation frequency. Bottom: simulation of
the EPR spectrum of [CoCo(E151A-AAP)] with gx,y = 2.29, gz ≈ 2.55, E/D = 0.08.

Discussion
In recent years, a significant amount of attention has been directed toward understanding the catalytic
mechanism of dinuclear metallohydrolases because of their involvement in numerous biological processes.
Although most healthy organisms maintain homeostasis, in an abnormal state, such as cancer, the tight control
of many processes does not occur. Therefore, understanding the mechanism by which peptides are hydrolyzed
may ultimately lead to the discovery of drugs that help combat health conditions such as neurological disorders,
cancer, and diseases caused by antibiotic-resistant bacteria. One of the enzymes in this group that has been
extensively characterized by kinetic, spectroscopic, and X-ray crystallographic studies is the amino peptidase
from A. proteolytica (V. proteolyticus; AAP). One active-site residue that is of particular interest is glutamate-151
(E151) since it has been shown to function as the active-site general acid/base.24 The proximity of the bridging
water molecule and metal ion ligands-H97 and E152 suggests that E151 may also stabilize the dinuclear active
site and play a role in tuning the Lewis acidity of the active site Zn(II) ions. Therefore, we have used a
combination of kinetic, thermodynamic, and spectroscopic data to evaluate the structural role of E151.
On the basis of kinetic data with Zn(II)-loaded enzymes, substitution of E151 with an aspartate results in a 2000fold decrease in kcat, whereas substitution of E151 with an alanine results in an inactive enzyme.24 Although not a
ligand to the metal ions in the dinuclear Zn(II) active site, metal binding studies indicate that substituting E151
markedly affects the metal-binding properties. ITC data indicate that, when E151 is substituted with aspartate,
Zn(II) binds ∼850 times more weakly compared to rAAP. Similarly, substitution of E151 with an alanine residue,
which cannot form hydrogen bonds within the active site, weakens the binding of the first Zn(II) ion by a
staggering 24 000 times. The largest change in Gibbs free energy can be observed in the first Zn(II) binding
event, with rAAP being the most- and E151A-AAP the least-exoenergetic process. These data correlate with the
activity measurements with rAAP being the most- and E151A-AAP the least-active and strongly suggest that the
first metal binding site accommodates the catalytically relevant metal ion. This seemingly unexpected
correlation, as E151 is not a direct ligand to the metal ions, underscores the importance of second-shell
interactions in the active site of metalloenzymes. Mutation of the residue in position 151 does not affect the
binding of the second Zn(II), and overall free energy is similar for rAAP, E151A-, and E151D-AAP. Substitution of
residue 151 has similar effects on Co(II) binding, weakening the interaction of metal ion with the active site of
the enzyme. In contrast to Zn(II) binding to rAAP, the two Co(II) bind to the enzyme with similar affinities.
However binding of Co(II) to E151D-AAP is only ∼150 times weaker for the first metal binding site but ∼7000

times weaker for the second equivalent of Co(II) compared to rAAP. Clearly, E151 is an important regulator of
the electron density around the active site metal ions.
Even though the metal Kd values are markedly affected by the elimination of E151, no major geometrical
changes are observed on the basis of electronic absorption spectra of Co(II)-substituted AAP enzymes; however,
the observed molar absorptivities for [Co_(E151D-AAP)] and [CoCo(E151D-AAP)] are approximately half those
observed for rAAP. Electronic absorption spectra of [Co_(E151A-AAP)] and [CoCo(E151A-AAP)] are similar to
those of rAAP, but the molar absorptivities are higher than those observed for Co(II)-loaded E151D-AAP. The
presence of a shoulder with λmax at 570 nm suggests an additional electronic transition, probably due to
distortion about the Co(II) ions. Consistent with electronic absorption spectra, EPR data obtained on
[CoCo(E151A-AAP)] suggest a rigid, pentacoordinate environment for the first metal ion. Further coordination
environment changes in the active site of E151D-AAP were obtained by recording the EPR spectrum of
[Co_(E151D-AAP)], which is very similar to that of [CoCo(AAP)] (g⊥(real) = g∥(real) ≈ 2.29 and E/D = 0.08), but
differs significantly from those of [Co_(AAP)], [CoZn(AAP)], and [ZnCo(AAP)] in that there was no rhombic
component that exhibits resolved hyperfine coupling.23 For [Co_(E151D-AAP)], the intensity of the electronic
transition observed at 521 nm (23 M-1 cm-1) and a featureless EPR signal, notably lacking the rhombic signal seen
in the spectrum of a [Co_(AAP)], indicate clear differences between E151D-AAP and wild-type or rAAP.
There are three possible explanations for the unusual spectroscopic behavior of E151D-AAP. First, it is possible
that the Co(II) ions bind cooperatively. In this case, samples of [Co_(E151D-AAP)] would really contain 50%
[CoCo(E151D-AAP)] and 50% apo-E151D-AAP while samples of [CoZn(E151D-AAP)] and [ZnCo(E151D-AAP)]
would really contain 50% [CoCo(E151D-AAP)] and [ZnZn(E151D-AAP)]. This scenario would explain the EPR data
adequately but not the electronic absorption data. A second explanation would consist of hexacoordinate
binding site for the first Co(II) ion in E151D-AAP rather than pentacoordinate. This would explain the electronic
absorption data and be consistent with the EPR of [Co_(E151D-AAP)] and [CoZn(E151D-AAP)]. However, the EPR
signal from [ZnCo(E151D-AAP)] would be expected to resemble that of the corresponding wild-type species; it
clearly does not. The third scenario would explain all the EPR data and the optical data but invokes a
combination of the first two explanations. If the “first” site is actually hexacoordinate (for Co(II)) in E151D-AAP
and Co(II) binds to this site cooperatively, then the EPR and optical data can be explained on the basis that a
doubly hexacoordinate [CoCo(E151D-AAP)] species, which is the only species observed in the EPR and optical
spectroscopic measurements. The most likely sixth ligand for Co1 would be a water molecule that is hydrogenbonded to D151. The presence of two slightly different species in the spectrum of [Co_(E151A-AAP)] has also
been observed in wild-type AAP under the conditions used and one of the species likely represents only a small
perturbation of the other by an OH-/H2O equilibrium.23,31
In conclusion, the combination of kinetic, ITC, and spectroscopic data has allowed the structural role of E151 to
be examined. E151 acts on several levels: (i) stabilizing the active site, (ii) preserving the coordination geometry
of the first, “tightly bound” metal ion, (iii) affecting the Lewis acidity of the metal ions through the interaction
with the bridging water molecule, as well as other metal ligands, (iv) positioning the nucleophile relative to the
substrate, and (v) acting as a general acid in the proposed mechanism of peptide hydrolysis by assisting in the
collapse of the tetrahedral intermediate.24 The combination of data presented herein with previously reported
kinetic data24 highlights the complexity of first and second sphere interactions that occur in the active sites of
metalloenzymes. These data also provide additional insight into our understanding of the role active site
residues (both metal ligands and nonligands) play in the hydrolysis of peptides by metalloenzymes that contain
dinuclear active sites.
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